Top Spinal Muscular Atrophy Treatment companies

Key players in Spinal Muscular Atrophy Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Spinal Muscular Atrophy Treatment market

#	Company	Website	Our reports
1	Biogen Inc	biogen.com (opens in a new tab)	264 reports
2	Novartis AG	novartis.com (opens in a new tab)	1,551 reports
3	Roche	roche.com (opens in a new tab)	1,485 reports
4	SScholar Rock	—	66 reports
5	BBiohaven	—	33 reports

Top trial sponsors in Spinal Muscular Atrophy Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

1. Biogen Inc 10 active trials on ClinicalTrials.gov (opens in a new tab)
2. Novartis AG 9 active trials on ClinicalTrials.gov (opens in a new tab)
3. GeneCradle Inc 4 active trials on ClinicalTrials.gov (opens in a new tab)
4. Roche 4 active trials on ClinicalTrials.gov (opens in a new tab)
5. Scholar Rock 2 active trials on ClinicalTrials.gov (opens in a new tab)
6. MarsiBionics 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Spinal Muscular Atrophy Treatment reports by place

One report for each place. Each tile opens that place's report.

Regions 7

Countries 26

Australia report Brazil report Canada report China report Ecuador report Egypt report France report Germany report Hong Kong report India report Italy report Japan report Kenya report Malaysia report Mexico report New Zealand report Philippines report Russia report Saudi Arabia report Singapore report South Africa report Spain report Thailand report UAE report UK report US report

Compare all 33 places for Spinal Muscular Atrophy Treatment, with active trials